Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

In vivo cytogenetic screening for determination of the mutagenic potential of cyclophosphamide

Barbărasă, C.; Luca, D.; Postică, F.; Covic, M.

Morphologie et Embryologie 25(4): 369-372

1979

ISSN/ISBN: 0377-5038
PMID: 160994
Document Number: 4232
Among the in vivo cytogenetic tests employed for chemically induced mutagenicity, a recent screening method was selected - the micronucleus test. The micronuclei were investigated, comparatively with chromosome breaks, on the bone marrow of Wistar rats after intraperitoneal administration of different doses of Cyclophosphamide (CY) applied in one or two injections at 24 hrs interval. The good relationship between these two tests was proved in evaluation of cytogenetic risk.

Document emailed within 1 workday
Secure & encrypted payments

In vivo cytogenetic screening for determination of the mutagenic potential of cyclophosphamide

Vasil'eva, I.M.; Sdirkova, N.I.; Zasukhina, G.D.; Butenko, P.G.; Krasovskiĭ, G.N. 1982: Determination of the mutagenic potential of an environmental pollutant, mercuric chloride Tsitologiia i Genetika 16(2): 21-24
Kalinina, L.M.; Polukhina, G.N.; Lukasheva, L.I. 1977: Salmonella typhimurium as a test system for detecting the mutagenic activity of environmental pollutants. I. the mutagenic action of heavy metal salts in in vivo and in vitro systems without metabolic activation Genetika 13(6): 1089-1092
Gichner, T.; Velemínský, J. 1987: The organic solvents acetone, ethanol and dimethylformamide potentiate the mutagenic activity of N-methyl-N'-nitro-N-nitrosoguanidine, but have no effect on the mutagenic potential of N-methyl-N-nitrosourea Mutation Research 192(1): 31-35
Sheth, A.R. 2011: In Vitro Screening Methods to Assess the Potential of in Vivo Precipitation of Injectable Formulations upon Intravenous Administration PDA Journal of Pharmaceutical Science and Technology 65(1): 71-80
Machemer, L.; Lorke, D. 1975: Method for testing mutagenic effects of chemicals on spermatogonia of the Chinese hamster: results obtained with cyclophosphamide, saccharin, and cyclamate Arzneimittel-Forschung 25(12): 1889-1896
Bishun, N.P. 1971: The cytogenetic effect of cyclophosphamide on a Burkitt tumour cell line (EB4) in vitro Mutation Research 11(2): 258-260
Kislova, N.M. 1972: Cytogenetic study of the mutagenic effect of carcinogens and their non-carcinogenic analogs on monolayer cell cultures of primary explants of newborn rats Tsitologiia 14(11): 1398-1404
Iurov, I.I.; Vorsanova, S.G.; Solov'ev, I.V.; Iurov, I.B. 2011: Original molecular cytogenetic approach to determining spontaneous chromosomal mutations in the interphase cells to evaluate the mutagenic activity of environmental factors Gigiena i Sanitariia 5: 90-94
Sauers, L.J.; Fruin, J.T. 1982: The mutagenic potential of 25 organophosphinate compounds Mutation Research 105(5): 299-302
Loknitskaia, N.N.; Rotenberg, I.S.; Fonshteĭn, L.M.; Shuliakovskaia, T.S. 1986: Study of promutagen biotransformation in the Ames test. III. the role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide Genetika 22(9): 2259-2264
Wilmer, J.L.; Erexson, G.L.; Kligerman, A.D. 1986: Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites Cancer Research 46(1): 203-210
Voĭtovich, A.M.; Nadzharian, L.A.; Kotelenets, A.I.; Afonin, V.I.; Davydovskiĭ, A.G.; Ushkov, A.A.; Gavrilenko, N.V. 2005: Estimation of potential mutagenic activity of 24-epibrassinolide Tsitologiia i Genetika 38(6): 49-53
Gans, E.H.; Sadiq, I.; Stoudemayer, T.; Stoudemayer, M.; Kligman, A.M. 2008: In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle Journal of Drugs in Dermatology: Jdd 7(1): 28-32
Koos, R.; Brandenburg, V.; Mahnken, A.H.; Schneider, R.; Dohmen, G.; Autschbach, R.üd.; Marx, N.; Kramann, R. 2013: Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study Journal of Heart Valve Disease 22(3): 317-325
Narasimhamurthy, K.; Muralidhara; Raina, P.L. 1999: Absence of in vivo mutagenic potency of heated and fried oils in mice Indian Journal of Experimental Biology 37(1): 50-55
Krivtsova, E.K.; Ingel, F.I.; Bratslavskiĭ, V.A.; Glotova, T.P.; Revazova, I.A. 1994: Potential mutagenic activity of water, air and soil samples in the Sosnovyi Bor region Gigiena i Sanitariia 7: 33-35
Durnev, A.D.; Daugel'-Dauge, N.O.; Korkina, L.G.; Seredenin, S.B.; Velichkovskiĭ, B.T. 1993: Remote effects in the mutagenic action of chrysotile asbestos and zeolite dusts in vivo Biulleten' Eksperimental'noi Biologii i Meditsiny 115(5): 484-486
Tarasov, V.A.; Abilev, S.K.; Velibelkov, R.M.; Aslanian, M.M. 2003: Effectiveness of a battery of tests to assess the potential mutagenic danger of chemical compounds Genetika 39(10): 1406-1417
Petrelli, G.; Mucci, N.; Siepi, G.; Pace, F. 1996: Agricultural antiparasitics evaluated for their potential cancerogenic, mutagenic and toxic reproductive effects La Medicina del Lavoro 87(2): 110-121
Akulenko, T.V. 1981: Cytogenetic studies of the effects of 5-fluorouracil in vivo Genetika 17(3): 560-562